Publication: The anaemia of Plasmodium vivax malaria
Issued Date
2012-06-19
Resource Type
ISSN
14752875
Other identifier(s)
2-s2.0-84862234371
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Malaria Journal. Vol.11, (2012)
Suggested Citation
Nicholas M. Douglas, Nicholas M. Anstey, Pierre A. Buffet, Jeanne R. Poespoprodjo, Tsin W. Yeo, Nicholas J. White, Ric N. Price The anaemia of Plasmodium vivax malaria. Malaria Journal. Vol.11, (2012). doi:10.1186/1475-2875-11-135 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/14304
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The anaemia of Plasmodium vivax malaria
Other Contributor(s)
Abstract
Plasmodium vivax threatens nearly half the worlds population and is a significant impediment to achievement of the millennium development goals. It is an important, but incompletely understood, cause of anaemia. This review synthesizes current evidence on the epidemiology, pathogenesis, treatment and consequences of vivax-associated anaemia. Young children are at high risk of clinically significant and potentially severe vivax-associated anaemia, particularly in countries where transmission is intense and relapses are frequent. Despite reaching lower densities than Plasmodium falciparum, Plasmodium vivax causes similar absolute reduction in red blood cell mass because it results in proportionately greater removal of uninfected red blood cells. Severe vivax anaemia is associated with substantial indirect mortality and morbidity through impaired resilience to co-morbidities, obstetric complications and requirement for blood transfusion. Anaemia can be averted by early and effective anti-malarial treatment. © 2012 Douglas et al.; licensee BioMed Central Ltd.